Site Name: UK - London - New Oxford Street, USA - Pennsylvania - Upper Providence Posted Date: Sep 27 2024 Senior Director, Global Real-World Evidence & Health Outcomes Research Lead - Belimumab For drugs to be successful, there must be robust health outcomes data to support launch optimization, reimbursement and maintain market position. Specifically, evidence must be maintained throughout the product lifecycle as standard of care changes, new competitors are introduced, and patents expire on existing competitors. The landscape is evolving quickly as trials demonstrating efficacy in an area of unmet need may receive expedited review, or orphan product status designation which affects both GSK and competitors launch timelines and approval requirements. More and more of our customers are developing sophisticated internal health outcomes capabilities and access to real world data that can be used to better understand unmet needs and real-world effectiveness of our...

GSK Senior Director, Global Real-World Evidence & Health Outcomes Research Lead - Pipeline (mRNA) Application closing date: October 7th 2024 (EOD) Chief Patient Organisation The Chief Patient Organisation led by the Chief Patient Officer is accountable for bringing external perspectives of thought leaders, academic institutions, and patient groups, along with internal insights, to elevate the patient voice and shape company strategy. This means GSK will deliver differentiated vaccines and medicines that address the unmet needs of people around the world - better and faster. Job purpose: For drugs to be successful, there must be robust health outcomes data to support launch optimization, reimbursement and maintain market position. Specifically, evidence must be maintained throughout the product lifecycle as standard of care changes, new competitors are introduced, and patents expire on existing competitors. The landscape is evolving quickly as...

GSK Senior Director, Global Real-World Evidence & Health Outcomes Research Lead - Oncology Pipeline Application closing date: October 7th 2024 (EOD) Chief Patient Organisation The Chief Patient Organisation led by the Chief Patient Officer is accountable for bringing external perspectives of thought leaders, academic institutions, and patient groups, along with internal insights, to elevate the patient voice and shape company strategy. This means GSK will deliver differentiated vaccines and medicines that address the unmet needs of people around the world - better and faster. Job purpose: For drugs to be successful, there must be robust health outcomes data to support launch optimization, reimbursement and maintain market position. Specifically, evidence must be maintained throughout the product lifecycle as standard of care changes, new competitors are introduced, and patents expire on existing competitors. The landscape is evolving quickly as...

GSK For drugs to be successful, there must be robust health outcomes data to support launch optimization, reimbursement and maintain market position. Specifically, evidence must be maintained throughout the product lifecycle as standard of care changes, new competitors are introduced, and patents expire on existing competitors. The landscape is evolving quickly as trials demonstrating efficacy in an area of unmet need may receive expedited review, or orphan product status designation which affects both GSK and competitors launch timelines and approval requirements. More and more of our customers are developing sophisticated internal health outcomes capabilities and access to real world data that can be used to better understand unmet needs and real-world effectiveness of our medicines. We need to better understand how our customers define value and to effectively collaborate with them to ensure we are generating value evidence data that includes real world evidence and cost...

GSK Senior Director, Global Real-World Evidence & Health Outcomes Research Lead - Herpes zoster For drugs to be successful, there must be robust health outcomes data to support launch optimization, reimbursement and maintain market position. Specifically, evidence must be maintained throughout the product lifecycle as standard of care changes, new competitors are introduced, and patents expire on existing competitors. The landscape is evolving quickly as trials demonstrating efficacy in an area of unmet need may receive expedited review, or orphan product status designation which affects both GSK and competitors launch timelines and approval requirements. More and more of our customers are developing sophisticated internal health outcomes capabilities and access to real world data that can be used to better understand unmet needs and real-world effectiveness of our medicines. We need to better understand how our customers define value and to effectively collaborate...

GSK Senior Director, Global Real-World Evidence & Health Outcomes Research Lead - RSV For drugs to be successful, there must be robust health outcomes data to support launch optimization, reimbursement and maintain market position. Specifically, evidence must be maintained throughout the product lifecycle as standard of care changes, new competitors are introduced, and patents expire on existing competitors. The landscape is evolving quickly as trials demonstrating efficacy in an area of unmet need may receive expedited review, or orphan product status designation which affects both GSK and competitors launch timelines and approval requirements. More and more of our customers are developing sophisticated internal health outcomes capabilities and access to real world data that can be used to better understand unmet needs and real-world effectiveness of our medicines. We need to better understand how our customers define value and to effectively collaborate with them...

GSK Senior Director, Global Real-World Evidence & Health Outcomes Research Lead - Pneumococcal MAPS For drugs to be successful, there must be robust health outcomes data to support launch optimization, reimbursement and maintain market position. Specifically, evidence must be maintained throughout the product lifecycle as standard of care changes, new competitors are introduced, and patents expire on existing competitors. The landscape is evolving quickly as trials demonstrating efficacy in an area of unmet need may receive expedited review, or orphan product status designation which affects both GSK and competitors launch timelines and approval requirements. More and more of our customers are developing sophisticated internal health outcomes capabilities and access to real world data that can be used to better understand unmet needs and real-world effectiveness of our medicines. We need to better understand how our customers define value and to effectively...

GSK Senior Director, Global Real-World Evidence & Health Outcomes Research Lead - Belimumab For drugs to be successful, there must be robust health outcomes data to support launch optimization, reimbursement and maintain market position. Specifically, evidence must be maintained throughout the product lifecycle as standard of care changes, new competitors are introduced, and patents expire on existing competitors. The landscape is evolving quickly as trials demonstrating efficacy in an area of unmet need may receive expedited review, or orphan product status designation which affects both GSK and competitors launch timelines and approval requirements. More and more of our customers are developing sophisticated internal health outcomes capabilities and access to real world data that can be used to better understand unmet needs and real-world effectiveness of our medicines. We need to better understand how our customers define value and to effectively collaborate with...

Site Name: UK - London - New Oxford Street, Belgium-Wavre, USA - Pennsylvania - Upper Providence Posted Date: Sep 23 2024 Senior Director, Global Real-World Evidence & Health Outcomes Research Lead - Herpes zoster For drugs to be successful, there must be robust health outcomes data to support launch optimization, reimbursement and maintain market position. Specifically, evidence must be maintained throughout the product lifecycle as standard of care changes, new competitors are introduced, and patents expire on existing competitors. The landscape is evolving quickly as trials demonstrating efficacy in an area of unmet need may receive expedited review, or orphan product status designation which affects both GSK and competitors launch timelines and approval requirements. More and more of our customers are developing sophisticated internal health outcomes capabilities and access to real world data that can be used to better understand unmet needs and real-world...

Site Name: UK - London - New Oxford Street, Belgium-Wavre, USA - Pennsylvania - Upper Providence Posted Date: Sep 23 2024 Senior Director, Global Real-World Evidence & Health Outcomes Research Lead - Pneumococcal MAPS For drugs to be successful, there must be robust health outcomes data to support launch optimization, reimbursement and maintain market position. Specifically, evidence must be maintained throughout the product lifecycle as standard of care changes, new competitors are introduced, and patents expire on existing competitors. The landscape is evolving quickly as trials demonstrating efficacy in an area of unmet need may receive expedited review, or orphan product status designation which affects both GSK and competitors launch timelines and approval requirements. More and more of our customers are developing sophisticated internal health outcomes capabilities and access to real world data that can be used to better understand unmet needs and real-world...

Site Name: UK - London - New Oxford Street, Belgium-Wavre, USA - Pennsylvania - Upper Providence Posted Date: Sep 23 2024 End date job posting: 7th October 2024 Chief Patient Organisation The Chief Patient Organisation led by the Chief Patient Officer is accountable for bringing external perspectives of thought leaders, academic institutions, and patient groups, along with internal insights, to elevate the patient voice and shape company strategy. This means GSK will deliver differentiated vaccines and medicines that address the unmet needs of people around the world - better and faster. Job purpose: For drugs to be successful, there must be robust health outcomes data to support launch optimization , reimbursement and maintain market position . Specifically, evidence must be maintained throughout the product lifecycle as standard of care changes, new competitors are introduced, and patents expire on existing competitors. The landscape is evolving quickly as...

Site Name: UK - London - New Oxford Street, USA - Pennsylvania - Upper Providence Posted Date: Sep 23 2024 End date job posting: 7th October 2024 Chief Patient Organisation The Chief Patient Organisation led by the Chief Patient Officer is accountable for bringing external perspectives of thought leaders, academic institutions, and patient groups, along with internal insights, to elevate the patient voice and shape company strategy. This means GSK will deliver differentiated vaccines and medicines that address the unmet needs of people around the world - better and faster. Job purpose: For drugs to be successful, there must be robust health outcomes data to support launch optimization , reimbursement and maintain market position . Specifically, evidence must be maintained throughout the product lifecycle as standard of care changes, new competitors are introduced, and patents expire on existing competitors. The landscape is evolving quickly as trials...

Site Name: UK - London - New Oxford Street, Belgium-Wavre, USA - Pennsylvania - Upper Providence Posted Date: Sep 23 2024 Senior Director, Global Real-World Evidence & Health Outcomes Research Lead - RSV For drugs to be successful, there must be robust health outcomes data to support launch optimization, reimbursement and maintain market position. Specifically, evidence must be maintained throughout the product lifecycle as standard of care changes, new competitors are introduced, and patents expire on existing competitors. The landscape is evolving quickly as trials demonstrating efficacy in an area of unmet need may receive expedited review, or orphan product status designation which affects both GSK and competitors launch timelines and approval requirements. More and more of our customers are developing sophisticated internal health outcomes capabilities and access to real world data that can be used to better understand unmet needs and real-world effectiveness of...

Site Name: USA - Pennsylvania - Upper Providence, UK - London - New Oxford Street Posted Date: Sep 24 2024 If you are an employee potentially impacted and at risk of redundancy, please add the following statement at the top of your CV: ‘ At Risk of Redundancy’. For drugs to be successful, there must be robust health outcomes data to support launch optimization , reimbursement and maintain market position . Specifically, evidence must be maintained throughout the product lifecycle as standard of care changes, new competitors are introduced, and patents expire on existing competitors. The landscape is evolving quickly as trials demonstrating efficacy in an area of unmet need may receive expedited review, or orphan product status designation which affects both GSK and competitors launch timelines and approval requirements. More and more of our customers are developing sophisticated internal health outcomes capabilities and access to real world data that can be used to better...

AstraZeneca We are building out a best-in-class Measurement Science team to support R&D as well as digital solutions including digital therapeutics, which will be part of the future of measurement science and analytics to support novel endpoints/interventions. Evinova is a health-tech business, accelerating the delivery of better health outcomes by propelling the life sciences sector forward in digital health, from the inside. Through our application of science-based expertise, evidence-led rigour, and human experience-driven insight, our digital solutions are deliberately designed so that everyone can reach better health outcomes together. Evinova is a health-tech business within the AstraZeneca Group. At AstraZeneca, we put patients first and strive to meet their unmet needs worldwide. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. If you are swift to action, confident to lead, willing to collaborate,...

AstraZeneca We are building out a best-in-class Measurement Science team to support R&D as well as digital solutions including digital therapeutics, which will be part of the future of measurement science and analytics to support novel endpoints/interventions. Evinova is a health-tech business, accelerating the delivery of better health outcomes by propelling the life sciences sector forward in digital health, from the inside. Through our application of science-based expertise, evidence-led rigour, and human experience-driven insight, our digital solutions are deliberately designed so that everyone can reach better health outcomes together. Evinova is a health-tech business within the AstraZeneca Group. At AstraZeneca, we put patients first and strive to meet their unmet needs worldwide. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. If you are swift to action, confident to lead, willing to collaborate,...

AstraZeneca We are building out a best-in-class Regulatory Science team to support R&D as well as digital solutions including digital therapeutics, which will be part of the future of measurement science and analytics to support novel endpoints/interventions. Evinova is a health-tech business, accelerating the delivery of better health outcomes by propelling the life sciences sector forward in digital health, from the inside. Through our application of science-based expertise, evidence-led rigour, and human experience-driven insight, our digital solutions are deliberately designed so that everyone can reach better health outcomes together. Evinova is a health-tech business within the AstraZeneca Group. At AstraZeneca, we put patients first and strive to meet their unmet needs worldwide. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. If you are swift to action, confident to lead, willing to collaborate,...

Syneos Health Description Senior Director, Data Analytics Real World Evidence (RWE) Syneos Health is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. Our Clinical Development model brings the customer and the patient to the center of everything that we do. We are continuously looking for ways to simplify and streamline our work to not only make Syneos Health easier to work with, but to make us easier to work for. Whether you join us in a Functional Service Provider partnership or a Full-Service environment, you'll collaborate with passionate problem solvers, innovating as a team to help our customers achieve their goals. We are agile and driven to accelerate the delivery of therapies, because we are passionate to change lives. Discover what our 29,000 employees, across 110 countries...

GSK Director, Global Real-World Evidence & Health Outcomes Research Lead - Essential/Established/Adult Application closing date: October 7th 2024 (EOD) Chief Patient Organisation The Chief Patient Organisation led by the Chief Patient Officer is accountable for bringing external perspectives of thought leaders, academic institutions, and patient groups, along with internal insights, to elevate the patient voice and shape company strategy. This means GSK will deliver differentiated vaccines and medicines that address the unmet needs of people around the world - better and faster. Job purpose: For drugs to be successful, there must be robust health outcomes data to support launch optimization, reimbursement and maintain market position. Specifically, evidence must be maintained throughout the product lifecycle as standard of care changes, new competitors are introduced, and patents expire on existing competitors. The landscape is evolving quickly...

GSK Director, Global Real-World Evidence & Health Outcomes Research Lead - Tebipenem Application closing date: October 7th 2024 (EOD) Chief Patient Organisation The Chief Patient Organisation led by the Chief Patient Officer is accountable for bringing external perspectives of thought leaders, academic institutions, and patient groups, along with internal insights, to elevate the patient voice and shape company strategy. This means GSK will deliver differentiated vaccines and medicines that address the unmet needs of people around the world - better and faster. Job purpose: For drugs to be successful, there must be robust health outcomes data to support launch optimization, reimbursement and maintain market position. Specifically, evidence must be maintained throughout the product lifecycle as standard of care changes, new competitors are introduced, and patents expire on existing competitors. The landscape is evolving quickly as trials...